These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9404998)

  • 1. Distorted colour discrimination in Parkinson's disease is related to severity of the disease.
    Müller T; Kuhn W; Büttner T; Przuntek H
    Acta Neurol Scand; 1997 Nov; 96(5):293-6. PubMed ID: 9404998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease.
    Müller T; Kuhn W; Büttner T; Eising E; Coenen H; Haas M; Przuntek H
    J Neurol; 1998 Oct; 245(10):659-64. PubMed ID: 9776465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of visual dysfunction in Parkinson's disease.
    Müller T; Woitalla D; Peters S; Kohla K; Przuntek H
    Acta Neurol Scand; 2002 Apr; 105(4):256-60. PubMed ID: 11939937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
    Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
    Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distorted color discrimination in 'de novo' parkinsonian patients.
    Büttner T; Kuhn W; Müller T; Patzold T; Heidbrink K; Przuntek H
    Neurology; 1995 Feb; 45(2):386-7. PubMed ID: 7854545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colour vision abnormalities and movement time in Parkinson's disease.
    Müller T; Kuhn W; Büttner T; Przuntek H
    Eur J Neurol; 1999 Nov; 6(6):711-5. PubMed ID: 10529760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Color vision deficiencies in Gilles de la Tourette syndrome.
    Melun JP; Morin LM; Muise JG; DesRosiers M
    J Neurol Sci; 2001 May; 186(1-2):107-10. PubMed ID: 11412879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.
    Hardy KJ; Lipton J; Scase MO; Foster DH; Scarpello JH
    Br J Ophthalmol; 1992 Aug; 76(8):461-4. PubMed ID: 1390526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of relationship between colour discrimination ability and stereoscopic acuity using Farnsworth Munsell 100 hue test and stereo tests.
    Koctekin B; Coban DT; Ozen M; Tekindal MA; Unal AC; Altintas AGK; Gundogan NU
    Can J Ophthalmol; 2020 Apr; 55(2):131-136. PubMed ID: 31712007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J; Dain SJ
    Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colour discrimination impairment is not a reliable early marker of Parkinson's disease.
    Veselá O; Růzicka E; Jech R; Roth J; Stepánková K; Mecír P; Solano Z; Preclíková E
    J Neurol; 2001 Nov; 248(11):975-8. PubMed ID: 11757962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor impairment influences Farnsworth-Munsell 100 Hue test error scores in Parkinson's disease patients.
    Müller T; Meisel M; Russ H; Przuntek H
    J Neurol Sci; 2003 Sep; 213(1-2):61-5. PubMed ID: 12873756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Dopa improves colour vision in Parkinson's disease.
    Büttner T; Kuhn W; Patzold T; Przuntek H
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):13-9. PubMed ID: 8579766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test.
    Regan BC; Freudenthaler N; Kolle R; Mollon JD; Paulus W
    Vision Res; 1998 Nov; 38(21):3427-31. PubMed ID: 9893860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colour discrimination and categorisation in Williams syndrome.
    Farran EK; Cranwell MB; Alvarez J; Franklin A
    Res Dev Disabil; 2013 Oct; 34(10):3352-60. PubMed ID: 23911545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for increasing the scoring efficiency of the Farnsworth-Munsell 100-Hue test.
    Craven BJ
    Ophthalmic Physiol Opt; 1997 Mar; 17(2):153-7. PubMed ID: 9196679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-perception and determinants of color vision in Parkinson's disease.
    Brandt AU; Zimmermann HG; Oberwahrenbrock T; Isensee J; Müller T; Paul F
    J Neural Transm (Vienna); 2018 Feb; 125(2):145-152. PubMed ID: 29143216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test.
    Thyagarajan S; Moradi P; Membrey L; Alistair D; Laidlaw H
    Ophthalmic Physiol Opt; 2007 May; 27(3):315-9. PubMed ID: 17470246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--I. Congenital colour vision defects.
    Dain SJ; Birch J
    Ophthalmic Physiol Opt; 1987; 7(3):267-80. PubMed ID: 3500446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of colour difference vectors in diagnosing congenital colour vision deficiencies with the Farnsworth-Munsell 100-hue test.
    Vingrys AJ; Atchison DA; Bowman KJ
    Ophthalmic Physiol Opt; 1992 Jan; 12(1):38-45. PubMed ID: 1584615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.